These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17562809)

  • 1. Effectiveness and renal tolerance of multidetector helical CT with gadobutrol: results of a comparative porcine study.
    Kalinowski M; Goldmann K; Gotthardt M; Rössler M; Pfestroff A; Klose KJ; Wagner HJ
    Radiology; 2007 Aug; 244(2):457-63. PubMed ID: 17562809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study.
    Kalinowski M; Kress O; Wels T; Alfke H; Klose KJ; Wagner HJ
    Invest Radiol; 2003 Apr; 38(4):193-9. PubMed ID: 12649642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study.
    Tombach B; Bremer C; Reimer P; Kisters K; Schaefer RM; Geens V; Heindel W
    Radiology; 2001 Mar; 218(3):651-7. PubMed ID: 11230635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
    Elmståhl B; Nyman U; Leander P; Golman K; Chai CM; Grant D; Doughty R; Pehrson R; Björk J; Almén T
    Radiology; 2008 Apr; 247(1):88-97. PubMed ID: 18292474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.
    Staks T; Schuhmann-Giampieri G; Frenzel T; Weinmann HJ; Lange L; Platzek J
    Invest Radiol; 1994 Jul; 29(7):709-15. PubMed ID: 7960618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysability.
    Tombach B; Bremer C; Reimer P; Matzkies F; Schaefer RM; Ebert W; Geens V; Eisele J; Heindel W
    AJR Am J Roentgenol; 2002 Jan; 178(1):105-9. PubMed ID: 11756100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-detector row CT of the kidney: optimizing scan delays for bolus tracking techniques of arterial, corticomedullary, and nephrographic phases.
    Goshima S; Kanematsu M; Nishibori H; Kondo H; Tsuge Y; Yokoyama R; Miyoshi T; Onozuka M; Shiratori Y; Moriyama N; Bae KT
    Eur J Radiol; 2007 Sep; 63(3):420-6. PubMed ID: 17367973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography.
    Schmitz SA; Wagner S; Schuhmann-Giampieri G; Wolf KJ
    Invest Radiol; 1995 Nov; 30(11):644-9. PubMed ID: 8557505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray digital subtraction angiography with 1 mol/L gadobutrol: results from a comparative porcine study With iodinated contrast agents.
    Kalinowski M; Kress O; Wels T; Alfke H; Klose KJ; Wagner HJ
    Invest Radiol; 2002 May; 37(5):254-62. PubMed ID: 11979151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
    Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
    Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations.
    Kunze C; Mentzel HJ; Krishnamurthy R; Fleck R; Stenzel M; Bhargava R; Burrowes D; Sutter G; Schultze-Mosgau M; Santiuste M; Hahn G
    Invest Radiol; 2016 Jan; 51(1):50-7. PubMed ID: 26340504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol.
    Tombach B; Benner T; Reimer P; Schuierer G; Fallenberg EM; Geens V; Wels T; Sorensen AG
    Radiology; 2003 Mar; 226(3):880-8. PubMed ID: 12601217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients.
    Hahn G; Sorge I; Gruhn B; Glutig K; Hirsch W; Bhargava R; Furtner J; Born M; Schröder C; Ahlström H; Kaiser S; Moritz JD; Kunze CW; Shroff M; Stokland E; Trnkova ZJ; Schultze-Mosgau M; Reif S; Bacher-Stier C; Mentzel HJ
    Invest Radiol; 2009 Dec; 44(12):776-83. PubMed ID: 19858730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure.
    Tombach B; Bremer C; Reimer P; Schaefer RM; Ebert W; Geens V; Heindel W
    Invest Radiol; 2000 Jan; 35(1):35-40. PubMed ID: 10639034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.
    Kuwatsuru R; Takahashi S; Umeoka S; Sugihara R; Zeng M; Huan Y; Peng W; Ma L; Guo L; Teng G; Yao W; Tozaki M; Endo M; Kaji S; Ro T; Tae Hahn S; Chul Kang B; Nishimura H; Sugawara Y; Katakami N; Breuer J; Aitoku Y
    J Magn Reson Imaging; 2015 Feb; 41(2):404-13. PubMed ID: 24692302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: a phase I trial.
    Boss A; Martirosian P; Gehrmann M; Artunc F; Risler T; Oesingmann N; Claussen CD; Schick F; Küper K; Schlemmer HP
    Radiology; 2007 Mar; 242(3):783-90. PubMed ID: 17209166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study.
    Glutig K; Bhargava R; Hahn G; Hirsch W; Kunze C; Mentzel HJ; Schaefer JF; Willinek W; Palkowitsch P;
    Pediatr Radiol; 2016 Aug; 46(9):1317-23. PubMed ID: 27041276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium as a CT contrast agent: assessment in a porcine model.
    Gierada DS; Bae KT
    Radiology; 1999 Mar; 210(3):829-34. PubMed ID: 10207488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.